A Causal Relationship Between Bone Mineral Density and Breast Cancer Risk: a Mendelian Randomization Study Based on East Asian Population

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2024 Sep 14

PMID 39277718

Authors

Ziyang Cheng

Hui Xu

Xin Wang

Tao Teng

Bin Li

Zhong Cao

Zhichao Li

Jiayi Zhang

Jin Xuan

Fengyi Zhang

Yaxin Chen

Yujie Li

Wenbo Wang

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer (BC) poses significant burdens on women globally. While past research suggests a potential link between bone mineral density (BMD) and BC risk, findings remain inconsistent. Our study aims to elucidate the causal relationship between BMD and BC in East Asians using bidirectional Mendelian randomization (MR).

Methods: Genetic association data for bone mineral density T-scores (BMD-T) and Z-scores (BMD-Z) (Sample size = 92,615) and BC from two different sources (Sample size1 = 98,283; Sample size2 = 79,550) were collected from publicly available genome-wide association studies (GWAS). Single-nucleotide polymorphisms (SNPs) associated with BMD-T and BMD-Z as phenotype-related instrumental variables (IVs) were used, with BC as the outcome. As the primary means of causal inference, the inverse variance weighted (IVW) approach was employed. Heterogeneity analysis was conducted using Cochran's Q test, while MR-Egger regression analysis was implemented to assess the pleiotropic effects of the IVs. Sensitivity analyses were performed using methods such as MR-Egger, weighted median, and weighted mode to analyze the robustness and reliability of the results. The MR-PRESSO method and the RadialMR were used to detect and remove outliers. The PhenoScanner V2 website was utilized to exclude confounding factors shared between BMD and BC. Besides, the Bonferroni correction was also used to adjust the significance threshold. Then, the meta-analysis method was applied to combine the MR analysis results from the two BC sources. Finally, a reverse MR analysis was conducted.

Results: The results of the IVW method were consolidated through meta-analysis, revealing a positive correlation between genetically predicted BMD-T ([Formula: see text], [Formula: see text], [Formula: see text]) and BMD-Z ([Formula: see text],[Formula: see text], [Formula: see text]) with increased BC risk. The Cochran's [Formula: see text] test and MR-Egger regression suggested that neither of these causal relationships was affected by heterogeneity or horizontal pleiotropy. The sensitivity analyses supported the IVW results, indicating the robustness of the findings. Reverse MR analysis showed no causal relationship between BC and BMD.

Conclusion: Our MR study results provide evidence for the causal relationship between BMD and BC risk in East Asian populations, suggesting that BMD screening is of great significance in detecting and preventing BC.

References

Wang Y, Liu F, Sun L, Jia Y, Yang P, Guo D . Association between human blood metabolome and the risk of breast cancer. Breast Cancer Res. 2023; 25(1):9. PMC: 9872401. DOI: 10.1186/s13058-023-01609-4. View

Song S, Guo Y, Yang Y, Fu D . Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther. 2022; 237:108168. DOI: 10.1016/j.pharmthera.2022.108168. View

Grenier D, Cooke A, Lix L, Metge C, Lu H, Leslie W . Bone mineral density and risk of postmenopausal breast cancer. Breast Cancer Res Treat. 2010; 126(3):679-86. DOI: 10.1007/s10549-010-1138-y. View

Kamat M, Blackshaw J, Young R, Surendran P, Burgess S, Danesh J . PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019; 35(22):4851-4853. PMC: 6853652. DOI: 10.1093/bioinformatics/btz469. View

Fraenkel M, Novack V, Liel Y, Koretz M, Siris E, Norton L . Association between bone mineral density and incidence of breast cancer. PLoS One. 2013; 8(8):e70980. PMC: 3733715. DOI: 10.1371/journal.pone.0070980. View

Lorentzon M . Treating osteoporosis to prevent fractures: current concepts and future developments. J Intern Med. 2019; 285(4):381-394. DOI: 10.1111/joim.12873. View

Suzuki Y, Tsunoda H, Kimura T, Yamauchi H . BMI change and abdominal circumference are risk factors for breast cancer, even in Asian women. Breast Cancer Res Treat. 2017; 166(3):919-925. DOI: 10.1007/s10549-017-4481-4. View

Ishigaki K, Akiyama M, Kanai M, Takahashi A, Kawakami E, Sugishita H . Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat Genet. 2020; 52(7):669-679. PMC: 7968075. DOI: 10.1038/s41588-020-0640-3. View

Kim B, Choi Y, Song Y, Park J, Noh H, Nguyen T . Bone mineral density and the risk of breast cancer: a case-control study of Korean women. Ann Epidemiol. 2013; 24(3):222-7. DOI: 10.1016/j.annepidem.2013.11.009. View

10.

Lupsa B, Insogna K . Bone Health and Osteoporosis. Endocrinol Metab Clin North Am. 2015; 44(3):517-30. DOI: 10.1016/j.ecl.2015.05.002. View

11.

Xie R, Huang X, Liu Q, Liu M . Positive association between high-density lipoprotein cholesterol and bone mineral density in U.S. adults: the NHANES 2011-2018. J Orthop Surg Res. 2022; 17(1):92. PMC: 8848786. DOI: 10.1186/s13018-022-02986-w. View

12.

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

13.

Visscher P, Brown M, McCarthy M, Yang J . Five years of GWAS discovery. Am J Hum Genet. 2012; 90(1):7-24. PMC: 3257326. DOI: 10.1016/j.ajhg.2011.11.029. View

14.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

15.

Brozek W, Nagel G, Ulmer H, Concin H . Bone Mineral Density and Breast Cancer Incidence and Mortality in Postmenopausal Women: A Long-Term Follow-Up Study. J Womens Health (Larchmt). 2018; 28(5):628-635. DOI: 10.1089/jwh.2018.7310. View

16.

Davies N, Holmes M, Davey Smith G . Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018; 362:k601. PMC: 6041728. DOI: 10.1136/bmj.k601. View

17.

Choi S, Whitman M, Shimpi A, Sempertegui N, Chiou A, Druso J . Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer. Nat Biomed Eng. 2023; 7(11):1455-1472. DOI: 10.1038/s41551-023-01077-3. View

18.

Burgess S, Timpson N, Ebrahim S, Davey Smith G . Mendelian randomization: where are we now and where are we going?. Int J Epidemiol. 2015; 44(2):379-88. DOI: 10.1093/ije/dyv108. View

19.

Trapani D, Ginsburg O, Fadelu T, Lin N, Hassett M, Ilbawi A . Global challenges and policy solutions in breast cancer control. Cancer Treat Rev. 2022; 104:102339. DOI: 10.1016/j.ctrv.2022.102339. View

20.

Buist D, LaCroix A, Barlow W, White E, Weiss N . Bone mineral density and breast cancer risk in postmenopausal women. J Clin Epidemiol. 2001; 54(4):417-22. DOI: 10.1016/s0895-4356(00)00301-2. View